Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

Clinical trial NCT00272662 · COMPLETED

Trial details

NCT number: NCT00272662
Sponsor: Affymax
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy Induced Anemia Cancer

Start date: 2006-01-01
Primary completion: 2007-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.